Organigram Holdings Inc (OGI)
$1.75
Live
Performance
- $1.74$1.79$1.75
0.57%
Downside
Day's Volatility :2.79%
Upside
2.23%
- $0.97$2.91$1.75
44.56%
Downside
52 Weeks Volatility :66.66%
Upside
39.86%
Returns
| Period | Organigram Holdings Inc | Sector (Health Care) | Index (Russel 2000) |
|---|---|---|---|
3 Months | 0.28% | 3.6% | 0.0% |
6 Months | -6.32% | 10.2% | 0.0% |
1 Year | 72.82% | 19.6% | 0.0% |
3 Years | -81.76% | 16.8% | -23.0% |
Highlights
Market Capitalization | 188.9M |
Book Value | $2.85 |
Earnings Per Share (EPS) | -1.82 |
Wall Street Target Price | 8.8 |
Profit Margin | -153.8% |
Operating Margin TTM | -12.29% |
Return On Assets TTM | -5.56% |
Return On Equity TTM | -54.53% |
Revenue TTM | 149.2M |
Revenue Per Share TTM | 1.84 |
Quarterly Revenue Growth YOY | -14.000000000000002% |
Gross Profit TTM | 35.1M |
EBITDA | -25.4M |
Diluted Eps TTM | -1.82 |
Quarterly Earnings Growth YOY | 0.0 |
EPS Estimate Current Year | -0.31 |
EPS Estimate Next Year | -0.07 |
EPS Estimate Current Quarter | -0.05 |
EPS Estimate Next Quarter | -0.04 |
Analyst Recommendation
- Current
- 1M Ago
- 3M Ago
Analyst Forecast
What analysts predicted
Upside of 402.86%
Technicals Summary
Sell
Neutral
Buy
Organigram Holdings Inc is currently in a neutral trading position according to technical analysis indicators.
Peers
| Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
|---|---|---|---|---|---|
 Organigram Holdings Inc | -0.56% | -6.32% | 72.82% | -81.76% | -87.5% |
 Neurocrine Biosciences Inc. | 0.22% | -11.71% | 9.36% | 13.47% | 21.32% |
 Haleon Plc Spon Ads | -5.08% | 20.69% | 22.01% | 36.17% | 36.17% |
 Zoetis Inc. | -0.16% | 32.8% | 16.08% | -7.35% | 52.85% |
 Viatris Inc. | 2.53% | 4.53% | 31.84% | -16.06% | -28.03% |
 Catalent, Inc. | 0.9% | 7.56% | 42.8% | -54.43% | 23.98% |
| Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
|---|---|---|---|---|---|---|---|---|
Organigram Holdings Inc | NA | NA | NA | -0.31 | -0.55 | -0.06 | NA | 2.85 |
Neurocrine Biosciences Inc. | 35.55 | 35.55 | 0.27 | 4.54 | 0.16 | 0.12 | NA | 24.87 |
Haleon Plc Spon Ads | 32.52 | 32.52 | 1.5 | 0.39 | 0.07 | 0.04 | 0.02 | 1.82 |
Zoetis Inc. | 37.9 | 37.9 | 2.64 | 5.83 | 0.49 | 0.14 | 0.01 | 10.94 |
Viatris Inc. | 224.4 | NA | 0.07 | 2.67 | -0.03 | 0.03 | 0.04 | 16.36 |
Catalent, Inc. | 211.02 | NA | 3.02 | 0.2 | -0.25 | 0.0 | NA | 19.91 |
| Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
|---|---|---|---|---|---|
Organigram Holdings Inc | Buy | $188.9M | -87.5% | NA | -153.8% |
Neurocrine Biosciences Inc. | Buy | $11.9B | 21.32% | 35.55 | 16.0% |
Haleon Plc Spon Ads | Buy | $45.6B | 36.17% | 32.52 | 9.66% |
Zoetis Inc. | Buy | $87.6B | 52.85% | 37.9 | 26.29% |
Viatris Inc. | Hold | $14.0B | -28.03% | 224.4 | -4.24% |
Catalent, Inc. | Hold | $10.9B | 23.98% | 211.02 | -23.81% |
Insights on Organigram Holdings Inc
Increasing Revenue
Revenue is up for the last 4 quarters, 36.45M → 41.06M (in $), with an average increase of 3.8% per quarter
Increasing Net Profit
Netprofit is up for the last 2 quarters, -27.07M → 2.81M (in $), with an average increase of 1060.8% per quarter
Vs NBIX
In the last 3 years, Organigram Holdings Inc has experienced a drawdown of -81.8%, however Neurocrine Biosciences Inc. resisted the overall trend and outperformed by 27.4%
Institutional Holdings
Tidal Investments LLC.
1.66%AdvisorShares Investments, LLC
0.92%Renaissance Technologies Corp
0.75%Bank of Montreal
0.43%BMO Capital Markets Corp.
0.43%Dimensional Fund Advisors, Inc.
0.24%
Company Information
as part of canada’s marihuana for medical purposes regulations (mmpr), organigram (tsx-v:ogi) is atlantic canada's original licensed producer of medical marijuana. we are dedicated to consistently providing our clients with the highest quality, organically grown medicine and service. if you have questions or want to learn more, visit www.organigram.ca or give our client services team a call at 1-855-961-9420.
Organization | Organigram Holdings Inc |
Employees | 914 |
CEO | Ms. Beena G. Goldenberg |
Industry | Pharmaceuticals: Other |
Discover More
Jpmorgan Betabuilders 1-5 Year Us Aggregate Bd Etf
$1.75
-1.69%
Invesco Bulletshares 2025 Hi
$1.75
-1.69%
Schwab International Dividend Equity Etf
$1.75
-1.69%
Blockchain Coinvestors Acquisition Corp.
$1.75
-1.69%
Allgiant Travel Company
$1.75
-1.69%
Rogers Corp
$1.75
-1.69%
Innovator Intl Developed 10 Buffer Etf - Quarterly
$1.75
-1.69%
Iheartmedia
$1.75
-1.69%
Lightpath Technologies Inc
$1.75
-1.69%